

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.71596672 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.71596672 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.68404804 |
| 4 | * negative T cell selection (GO:0043383) | 7.65652486 |
| 5 | * negative thymic T cell selection (GO:0045060) | 6.89526022 |
| 6 | positive T cell selection (GO:0043368) | 6.89327354 |
| 7 | response to interleukin-15 (GO:0070672) | 6.85088092 |
| 8 | interferon-gamma production (GO:0032609) | 6.74436457 |
| 9 | positive thymic T cell selection (GO:0045059) | 6.74096313 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.64916805 |
| 11 | cellular response to interleukin-15 (GO:0071350) | 6.58669019 |
| 12 | tolerance induction (GO:0002507) | 6.58222342 |
| 13 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.02056421 |
| 14 | * T cell selection (GO:0045058) | 6.01953755 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.00238964 |
| 16 | * thymic T cell selection (GO:0045061) | 5.87922491 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.76043651 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.72309408 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.72309408 |
| 20 | positive regulation of granulocyte differentiation (GO:0030854) | 5.60232665 |
| 21 | activated T cell proliferation (GO:0050798) | 5.33923088 |
| 22 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 5.30834517 |
| 23 | * T cell receptor signaling pathway (GO:0050852) | 5.21690590 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.13896823 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 5.13458302 |
| 26 | T cell migration (GO:0072678) | 5.09251163 |
| 27 | leukocyte aggregation (GO:0070486) | 5.01767847 |
| 28 | gonadal mesoderm development (GO:0007506) | 4.98488631 |
| 29 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.97214849 |
| 30 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.97214849 |
| 31 | * T cell costimulation (GO:0031295) | 4.85767027 |
| 32 | * lymphocyte costimulation (GO:0031294) | 4.78510380 |
| 33 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.77858033 |
| 34 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.76845585 |
| 35 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.76845585 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.74531075 |
| 37 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.37859630 |
| 38 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.33855120 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.29779841 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.23706634 |
| 41 | * positive regulation of interleukin-2 production (GO:0032743) | 4.20033897 |
| 42 | positive regulation of tolerance induction (GO:0002645) | 4.18237937 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.96232075 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94907557 |
| 45 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.93539819 |
| 46 | regulation of regulatory T cell differentiation (GO:0045589) | 3.92642976 |
| 47 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.88336140 |
| 48 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.87585079 |
| 49 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.85155320 |
| 50 | alpha-beta T cell differentiation (GO:0046632) | 3.81041741 |
| 51 | alpha-beta T cell activation (GO:0046631) | 3.78658422 |
| 52 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.68168538 |
| 53 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.67405103 |
| 54 | positive regulation of B cell differentiation (GO:0045579) | 3.66486110 |
| 55 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.66207044 |
| 56 | regulation of granulocyte differentiation (GO:0030852) | 3.65640131 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.64978774 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.64584424 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.64385165 |
| 60 | positive regulation of cell killing (GO:0031343) | 3.62878409 |
| 61 | regulation of cell killing (GO:0031341) | 3.62505730 |
| 62 | mast cell activation (GO:0045576) | 3.59465967 |
| 63 | * T cell differentiation (GO:0030217) | 3.58500069 |
| 64 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.53188960 |
| 65 | positive regulation of humoral immune response (GO:0002922) | 3.52101959 |
| 66 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.50091925 |
| 67 | Peyers patch development (GO:0048541) | 3.44300835 |
| 68 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.44300835 |
| 69 | T cell proliferation (GO:0042098) | 3.42536435 |
| 70 | regulation of response to interferon-gamma (GO:0060330) | 3.41175563 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40652327 |
| 72 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.40616447 |
| 73 | leukocyte cell-cell adhesion (GO:0007159) | 3.38166340 |
| 74 | * regulation of interleukin-2 production (GO:0032663) | 3.36415844 |
| 75 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.34794325 |
| 76 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.32028410 |
| 77 | * regulation of isotype switching (GO:0045191) | 3.29661658 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29393732 |
| 79 | regulation of B cell differentiation (GO:0045577) | 3.27657498 |
| 80 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.26458586 |
| 81 | * T cell activation (GO:0042110) | 3.25959531 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23903767 |
| 83 | regulation of chronic inflammatory response (GO:0002676) | 3.23312994 |
| 84 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.23186217 |
| 85 | * positive regulation of isotype switching (GO:0045830) | 3.22963008 |
| 86 | positive regulation of interleukin-4 production (GO:0032753) | 3.22151266 |
| 87 | type I interferon signaling pathway (GO:0060337) | 3.22149408 |
| 88 | cellular response to type I interferon (GO:0071357) | 3.22149408 |
| 89 | T cell homeostasis (GO:0043029) | 3.21540558 |
| 90 | T-helper cell differentiation (GO:0042093) | 3.21061392 |
| 91 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.21061392 |
| 92 | response to type I interferon (GO:0034340) | 3.20913219 |
| 93 | lymphocyte migration (GO:0072676) | 3.17986703 |
| 94 | NIK/NF-kappaB signaling (GO:0038061) | 3.17425019 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.16253883 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16029087 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16029087 |
| 98 | positive regulation of immune response to tumor cell (GO:0002839) | 3.13653728 |
| 99 | regulation of immune response to tumor cell (GO:0002837) | 3.13653728 |
| 100 | regulation of response to tumor cell (GO:0002834) | 3.13653728 |
| 101 | positive regulation of response to tumor cell (GO:0002836) | 3.13653728 |
| 102 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.12976110 |
| 103 | * regulation of immunoglobulin production (GO:0002637) | 3.10900078 |
| 104 | * regulation of alpha-beta T cell activation (GO:0046634) | 3.09480603 |
| 105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09084141 |
| 106 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.08479818 |
| 107 | negative regulation of adaptive immune response (GO:0002820) | 3.08304026 |
| 108 | * positive regulation of B cell mediated immunity (GO:0002714) | 3.06694345 |
| 109 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.06694345 |
| 110 | * positive regulation of T cell activation (GO:0050870) | 3.06229596 |
| 111 | natural killer cell activation (GO:0030101) | 3.02623684 |
| 112 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.00988209 |
| 113 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.00988209 |
| 114 | T cell differentiation involved in immune response (GO:0002292) | 3.00988209 |
| 115 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00487238 |
| 116 | hepatocyte apoptotic process (GO:0097284) | 2.99725073 |
| 117 | regulation of interleukin-4 production (GO:0032673) | 2.99612505 |
| 118 | lymphocyte homeostasis (GO:0002260) | 2.99548303 |
| 119 | natural killer cell differentiation (GO:0001779) | 2.98820418 |
| 120 | * regulation of B cell mediated immunity (GO:0002712) | 2.98464615 |
| 121 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.98121833 |
| 122 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.98005447 |
| 123 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.97272426 |
| 124 | * regulation of lymphocyte mediated immunity (GO:0002706) | 2.96753187 |
| 125 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.96268013 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 2.95562374 |
| 127 | heterotypic cell-cell adhesion (GO:0034113) | 2.95474837 |
| 128 | positive regulation of B cell proliferation (GO:0030890) | 2.94552156 |
| 129 | mast cell activation involved in immune response (GO:0002279) | 2.93249676 |
| 130 | mast cell degranulation (GO:0043303) | 2.93249676 |
| 131 | positive regulation of T cell differentiation (GO:0045582) | 2.93024407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.40698197 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.72628484 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.23455393 |
| 4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.06115919 |
| 5 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.82759164 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65281306 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.59924916 |
| 8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.57030087 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.56761598 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.39179944 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.34656942 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18145573 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.12842364 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02770804 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.83930885 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.80706290 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.68214723 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.60033808 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57007608 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.40468449 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.39524072 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31077692 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18411145 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10523630 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 2.08566239 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07334112 |
| 27 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.03667328 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02174319 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99771529 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99752659 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.99399753 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95507259 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93045961 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.92581629 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87759178 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85994431 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83304841 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68844791 |
| 39 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66142029 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62405564 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59704958 |
| 42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59363234 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55784799 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51931399 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49035914 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46293623 |
| 47 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41790377 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39535252 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35280221 |
| 50 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34701027 |
| 51 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33693222 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29263849 |
| 53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.26681967 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.26620776 |
| 55 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25290312 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22688572 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21980456 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20806635 |
| 59 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20280679 |
| 60 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.16914380 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12801088 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12272460 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11429441 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11088327 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10973445 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09679003 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06092266 |
| 68 | GATA3_26560356_Chip-Seq_TH1_Human | 1.03733765 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02157535 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02020635 |
| 71 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98448101 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97970465 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97759806 |
| 74 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97494514 |
| 75 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96369187 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96177832 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95720134 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94490087 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92264686 |
| 80 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91011572 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90935835 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89118854 |
| 83 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85331225 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85130221 |
| 85 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84920425 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81888215 |
| 87 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81816240 |
| 88 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81740018 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81615934 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81165108 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80959046 |
| 92 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80259143 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80186381 |
| 94 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79962875 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79156954 |
| 96 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78609672 |
| 97 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76240854 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.73660986 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72764048 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.72308504 |
| 101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72032709 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71894365 |
| 103 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.71216354 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.70660593 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70265885 |
| 106 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70225198 |
| 107 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69476942 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67987988 |
| 109 | P300_27268052_Chip-Seq_Bcells_Human | 0.67841072 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66565917 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.64330203 |
| 112 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63621745 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.63375651 |
| 114 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63314336 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.63186590 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62859410 |
| 117 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.62276563 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.61535214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 5.55151741 |
| 2 | * MP0005671_abnormal_response_to | 4.07974534 |
| 3 | MP0000685_abnormal_immune_system | 3.46527171 |
| 4 | * MP0001800_abnormal_humoral_immune | 3.19640240 |
| 5 | MP0005387_immune_system_phenotype | 3.17380160 |
| 6 | MP0001790_abnormal_immune_system | 3.17380160 |
| 7 | MP0002166_altered_tumor_susceptibility | 3.15121937 |
| 8 | MP0003436_decreased_susceptibility_to | 3.14053577 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.08156073 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.02436442 |
| 11 | MP0006082_CNS_inflammation | 2.87773628 |
| 12 | * MP0002723_abnormal_immune_serum | 2.83254191 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.82022341 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.79749716 |
| 15 | MP0000703_abnormal_thymus_morphology | 2.78010265 |
| 16 | * MP0001819_abnormal_immune_cell | 2.77236665 |
| 17 | MP0002405_respiratory_system_inflammati | 2.75038772 |
| 18 | MP0009785_altered_susceptibility_to | 2.66299969 |
| 19 | MP0002006_tumorigenesis | 2.62183645 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.62010612 |
| 21 | * MP0009333_abnormal_splenocyte_physiolog | 2.61798759 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.47609361 |
| 23 | * MP0000716_abnormal_immune_system | 2.44959802 |
| 24 | MP0002933_joint_inflammation | 2.43819767 |
| 25 | MP0002722_abnormal_immune_system | 2.36284003 |
| 26 | * MP0005025_abnormal_response_to | 2.35328265 |
| 27 | MP0010155_abnormal_intestine_physiology | 2.31352921 |
| 28 | * MP0000689_abnormal_spleen_morphology | 2.29138802 |
| 29 | MP0003866_abnormal_defecation | 2.22254097 |
| 30 | MP0004947_skin_inflammation | 2.21355755 |
| 31 | MP0001873_stomach_inflammation | 2.14911583 |
| 32 | MP0002396_abnormal_hematopoietic_system | 2.13494001 |
| 33 | MP0003724_increased_susceptibility_to | 2.00467480 |
| 34 | * MP0002429_abnormal_blood_cell | 2.00448047 |
| 35 | MP0002419_abnormal_innate_immunity | 1.89452369 |
| 36 | * MP0002148_abnormal_hypersensitivity_rea | 1.84692526 |
| 37 | MP0000858_altered_metastatic_potential | 1.81785531 |
| 38 | MP0003303_peritoneal_inflammation | 1.79398779 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.71597302 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.58598718 |
| 41 | MP0001853_heart_inflammation | 1.52249994 |
| 42 | MP0004381_abnormal_hair_follicle | 1.50414424 |
| 43 | MP0004510_myositis | 1.49874108 |
| 44 | MP0003448_altered_tumor_morphology | 1.49731808 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.48530797 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.45136626 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.36349361 |
| 48 | MP0005310_abnormal_salivary_gland | 1.29547098 |
| 49 | MP0002009_preneoplasia | 1.25132781 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.24839619 |
| 51 | MP0000490_abnormal_crypts_of | 1.15555421 |
| 52 | MP0001851_eye_inflammation | 1.14811361 |
| 53 | * MP0008469_abnormal_protein_level | 1.09658493 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.09522153 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.07904601 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.06173628 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.05373851 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.03652579 |
| 59 | MP0008057_abnormal_DNA_replication | 1.03308003 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 0.99442601 |
| 61 | MP0001545_abnormal_hematopoietic_system | 0.99442601 |
| 62 | MP0002163_abnormal_gland_morphology | 0.96790012 |
| 63 | MP0001919_abnormal_reproductive_system | 0.90457919 |
| 64 | MP0005451_abnormal_body_composition | 0.85473831 |
| 65 | MP0004130_abnormal_muscle_cell | 0.84902133 |
| 66 | MP0008007_abnormal_cellular_replicative | 0.83356773 |
| 67 | MP0002132_abnormal_respiratory_system | 0.80294576 |
| 68 | MP0005023_abnormal_wound_healing | 0.77518820 |
| 69 | MP0003077_abnormal_cell_cycle | 0.76685596 |
| 70 | MP0003828_pulmonary_edema | 0.75620391 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.75535183 |
| 72 | MP0010094_abnormal_chromosome_stability | 0.72879819 |
| 73 | * MP0002693_abnormal_pancreas_physiology | 0.72418965 |
| 74 | MP0003045_fibrosis | 0.71114371 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.70871839 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.70259751 |
| 77 | MP0000604_amyloidosis | 0.68476328 |
| 78 | MP0008995_early_reproductive_senescence | 0.66893963 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.66556811 |
| 80 | MP0009763_increased_sensitivity_to | 0.66118346 |
| 81 | MP0001243_abnormal_dermal_layer | 0.65895307 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.65799508 |
| 83 | MP0009764_decreased_sensitivity_to | 0.64493094 |
| 84 | MP0004883_abnormal_blood_vessel | 0.63938487 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.63742240 |
| 86 | MP0009278_abnormal_bone_marrow | 0.62429710 |
| 87 | MP0003795_abnormal_bone_structure | 0.61372291 |
| 88 | MP0003693_abnormal_embryo_hatching | 0.59882327 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.59701548 |
| 90 | MP0003786_premature_aging | 0.59069091 |
| 91 | MP0000609_abnormal_liver_physiology | 0.58913995 |
| 92 | MP0001191_abnormal_skin_condition | 0.58577767 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.58259977 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.57627987 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.56932420 |
| 96 | MP0005390_skeleton_phenotype | 0.56551814 |
| 97 | MP0001881_abnormal_mammary_gland | 0.55849317 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.55781527 |
| 99 | MP0005166_decreased_susceptibility_to | 0.55398401 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.53807564 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.52674411 |
| 102 | MP0008260_abnormal_autophagy | 0.52138130 |
| 103 | MP0002928_abnormal_bile_duct | 0.50113343 |
| 104 | MP0000569_abnormal_digit_pigmentation | 0.50057332 |
| 105 | MP0001501_abnormal_sleep_pattern | 0.49138353 |
| 106 | MP0003787_abnormal_imprinting | 0.48270955 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.47798867 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.47142291 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.46949964 |
| 110 | MP0000249_abnormal_blood_vessel | 0.46904614 |
| 111 | MP0000627_abnormal_mammary_gland | 0.46872247 |
| 112 | MP0008873_increased_physiological_sensi | 0.46324156 |
| 113 | MP0010307_abnormal_tumor_latency | 0.46278535 |
| 114 | MP0001663_abnormal_digestive_system | 0.45019352 |
| 115 | MP0000313_abnormal_cell_death | 0.43862689 |
| 116 | MP0004957_abnormal_blastocyst_morpholog | 0.43670816 |
| 117 | MP0003091_abnormal_cell_migration | 0.43455117 |
| 118 | MP0008569_lethality_at_weaning | 0.41455113 |
| 119 | MP0003252_abnormal_bile_duct | 0.40093081 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.39665394 |
| 121 | MP0002083_premature_death | 0.39639396 |
| 122 | MP0009115_abnormal_fat_cell | 0.38610978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.21577808 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.81828053 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 5.93941535 |
| 4 | Stomatitis (HP:0010280) | 5.71058734 |
| 5 | Abnormality of T cells (HP:0002843) | 5.50587344 |
| 6 | Combined immunodeficiency (HP:0005387) | 5.44162977 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.29451523 |
| 8 | Chronic diarrhea (HP:0002028) | 4.77045922 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.73321918 |
| 10 | IgG deficiency (HP:0004315) | 4.63019667 |
| 11 | IgM deficiency (HP:0002850) | 4.59724817 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.57240833 |
| 13 | Abnormality of B cell number (HP:0010975) | 4.44731747 |
| 14 | B lymphocytopenia (HP:0010976) | 4.44731747 |
| 15 | Recurrent viral infections (HP:0004429) | 4.43123734 |
| 16 | Myositis (HP:0100614) | 4.23673186 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.13598111 |
| 18 | Thyroiditis (HP:0100646) | 4.03006046 |
| 19 | Abnormality of eosinophils (HP:0001879) | 4.00141440 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.95371723 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.95371723 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.85974090 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.69227391 |
| 24 | Eosinophilia (HP:0001880) | 3.68865154 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.56222602 |
| 26 | Optic neuritis (HP:0100653) | 3.56222602 |
| 27 | Joint swelling (HP:0001386) | 3.55535774 |
| 28 | Leukocytosis (HP:0001974) | 3.54694816 |
| 29 | Pustule (HP:0200039) | 3.51781555 |
| 30 | Increased IgM level (HP:0003496) | 3.49741565 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.46703630 |
| 32 | Nasal polyposis (HP:0100582) | 3.46690285 |
| 33 | Chronic otitis media (HP:0000389) | 3.41842826 |
| 34 | IgA deficiency (HP:0002720) | 3.40268333 |
| 35 | Hemoptysis (HP:0002105) | 3.32666937 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.25591597 |
| 37 | Pulmonary infiltrates (HP:0002113) | 3.15866634 |
| 38 | Hypoplasia of the thymus (HP:0000778) | 3.14243432 |
| 39 | Granulocytopenia (HP:0001913) | 3.10562729 |
| 40 | Orchitis (HP:0100796) | 3.07203668 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.03590723 |
| 42 | Abnormality of the prostate (HP:0008775) | 3.01377769 |
| 43 | Vasculitis (HP:0002633) | 2.98584008 |
| 44 | Lymphopenia (HP:0001888) | 2.98445841 |
| 45 | Autoimmune hemolytic anemia (HP:0001890) | 2.98243159 |
| 46 | Meningitis (HP:0001287) | 2.97149902 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.94742948 |
| 48 | Stomach cancer (HP:0012126) | 2.90990486 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.88599210 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.88160592 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.85464541 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.85117070 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.84982138 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83889151 |
| 55 | Obstructive lung disease (HP:0006536) | 2.83889151 |
| 56 | Arterial thrombosis (HP:0004420) | 2.83382857 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.79573213 |
| 58 | Abnormality of the nasal mucosa (HP:0000433) | 2.79273585 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.76502975 |
| 60 | Lymphoma (HP:0002665) | 2.76481141 |
| 61 | Papilledema (HP:0001085) | 2.76477006 |
| 62 | Basal cell carcinoma (HP:0002671) | 2.60669657 |
| 63 | Ureteral stenosis (HP:0000071) | 2.60267514 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.56925724 |
| 65 | Encephalitis (HP:0002383) | 2.54347598 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.52271507 |
| 67 | Bronchitis (HP:0012387) | 2.46487569 |
| 68 | Acute hepatic failure (HP:0006554) | 2.46056980 |
| 69 | Ureteral obstruction (HP:0006000) | 2.45558399 |
| 70 | Recurrent skin infections (HP:0001581) | 2.44726156 |
| 71 | Amaurosis fugax (HP:0100576) | 2.42251856 |
| 72 | Pulmonary embolism (HP:0002204) | 2.41728167 |
| 73 | Cheilitis (HP:0100825) | 2.39611272 |
| 74 | Spontaneous hematomas (HP:0007420) | 2.35365449 |
| 75 | Hypochromic anemia (HP:0001931) | 2.33499903 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.33364560 |
| 77 | Chest pain (HP:0100749) | 2.31359791 |
| 78 | Abnormality of binocular vision (HP:0011514) | 2.30405084 |
| 79 | Diplopia (HP:0000651) | 2.30405084 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.29877508 |
| 81 | Slow saccadic eye movements (HP:0000514) | 2.28671397 |
| 82 | Gangrene (HP:0100758) | 2.23550408 |
| 83 | Increased density of long bones (HP:0006392) | 2.09817777 |
| 84 | Urticaria (HP:0001025) | 2.09058813 |
| 85 | Thrombocytosis (HP:0001894) | 2.07087209 |
| 86 | Verrucae (HP:0200043) | 2.06346853 |
| 87 | Papilloma (HP:0012740) | 2.06346853 |
| 88 | Colitis (HP:0002583) | 2.04987292 |
| 89 | Epistaxis (HP:0000421) | 2.02636626 |
| 90 | Increased IgE level (HP:0003212) | 2.00599493 |
| 91 | Microcytic anemia (HP:0001935) | 2.00375137 |
| 92 | Gingivitis (HP:0000230) | 1.98545754 |
| 93 | Periodontitis (HP:0000704) | 1.97058599 |
| 94 | Anorexia (HP:0002039) | 1.96856875 |
| 95 | Abnormality of the pleura (HP:0002103) | 1.95257928 |
| 96 | Prostate neoplasm (HP:0100787) | 1.95222574 |
| 97 | Recurrent otitis media (HP:0000403) | 1.93474071 |
| 98 | Recurrent bacterial skin infections (HP:0005406) | 1.93426667 |
| 99 | Agammaglobulinemia (HP:0004432) | 1.92049882 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.90395153 |
| 101 | Keratitis (HP:0000491) | 1.89605639 |
| 102 | Persistence of primary teeth (HP:0006335) | 1.89357082 |
| 103 | Hematochezia (HP:0002573) | 1.87072411 |
| 104 | Gastrointestinal stroma tumor (HP:0100723) | 1.86261722 |
| 105 | Abnormal platelet volume (HP:0011876) | 1.85688399 |
| 106 | Petechiae (HP:0000967) | 1.84868217 |
| 107 | Fatigue (HP:0012378) | 1.84585718 |
| 108 | Glomerulopathy (HP:0100820) | 1.84160043 |
| 109 | Alveolar cell carcinoma (HP:0006519) | 1.82110187 |
| 110 | Hypoproteinemia (HP:0003075) | 1.80473874 |
| 111 | Arthralgia (HP:0002829) | 1.78766074 |
| 112 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76945491 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76704887 |
| 114 | Polyneuropathy (HP:0001271) | 1.76553339 |
| 115 | Emphysema (HP:0002097) | 1.71985096 |
| 116 | Skin ulcer (HP:0200042) | 1.70936145 |
| 117 | Abnormality of the endocardium (HP:0004306) | 1.70649743 |
| 118 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.70533851 |
| 119 | Gingival bleeding (HP:0000225) | 1.69874426 |
| 120 | Pulmonary fibrosis (HP:0002206) | 1.68865779 |
| 121 | Hepatitis (HP:0012115) | 1.68226527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.97635783 |
| 2 | MAP4K1 | 5.91629305 |
| 3 | JAK3 | 3.51003021 |
| 4 | ZAP70 | 3.17139205 |
| 5 | * ITK | 2.93182376 |
| 6 | FGFR4 | 2.72208554 |
| 7 | STK10 | 2.49507460 |
| 8 | IKBKE | 2.35218625 |
| 9 | RIPK4 | 2.33091039 |
| 10 | TYK2 | 2.31592540 |
| 11 | MAP3K14 | 2.28807100 |
| 12 | NLK | 2.26159637 |
| 13 | CAMKK2 | 2.22277336 |
| 14 | TEC | 2.17484382 |
| 15 | * LCK | 1.95422144 |
| 16 | JAK1 | 1.94586011 |
| 17 | GRK6 | 1.90418078 |
| 18 | FGFR3 | 1.86660773 |
| 19 | HCK | 1.62893891 |
| 20 | NME2 | 1.62090081 |
| 21 | CAMKK1 | 1.60021975 |
| 22 | CSK | 1.58564632 |
| 23 | BTK | 1.49650609 |
| 24 | SYK | 1.45640545 |
| 25 | TBK1 | 1.44031837 |
| 26 | MST4 | 1.42224160 |
| 27 | PRKCQ | 1.38969196 |
| 28 | EEF2K | 1.28559587 |
| 29 | MAP3K13 | 1.13092963 |
| 30 | IKBKB | 1.12708501 |
| 31 | CDK12 | 1.10474266 |
| 32 | SIK3 | 1.09766242 |
| 33 | KDR | 1.08387979 |
| 34 | BLK | 1.08016706 |
| 35 | TESK2 | 1.07782404 |
| 36 | IRAK4 | 1.01911908 |
| 37 | EPHA3 | 1.00312383 |
| 38 | EPHB1 | 0.98601855 |
| 39 | CLK1 | 0.98588214 |
| 40 | PRKCH | 0.98505339 |
| 41 | CHUK | 0.98099738 |
| 42 | MAP3K10 | 0.98081901 |
| 43 | PIM1 | 0.95579926 |
| 44 | JAK2 | 0.95287488 |
| 45 | LRRK2 | 0.88113079 |
| 46 | MARK3 | 0.86355004 |
| 47 | PKN2 | 0.85993050 |
| 48 | PIK3CG | 0.85594639 |
| 49 | KIT | 0.83891509 |
| 50 | SIK2 | 0.81803431 |
| 51 | TSSK6 | 0.81652299 |
| 52 | MELK | 0.77936985 |
| 53 | LYN | 0.76260407 |
| 54 | MAP3K7 | 0.76242730 |
| 55 | FES | 0.73143642 |
| 56 | PDGFRB | 0.72223196 |
| 57 | TNK2 | 0.69875562 |
| 58 | RPS6KA4 | 0.68565045 |
| 59 | TRIB3 | 0.67996981 |
| 60 | FRK | 0.67156478 |
| 61 | NUAK1 | 0.66409151 |
| 62 | TYRO3 | 0.66252327 |
| 63 | TGFBR2 | 0.65467397 |
| 64 | CDK6 | 0.63027588 |
| 65 | CDK4 | 0.61892153 |
| 66 | TAOK3 | 0.61468542 |
| 67 | MAP2K2 | 0.59119044 |
| 68 | TTN | 0.57552462 |
| 69 | MAP3K1 | 0.55701834 |
| 70 | ALK | 0.55245028 |
| 71 | TLK1 | 0.54375742 |
| 72 | ADRBK2 | 0.53257528 |
| 73 | MAPK7 | 0.51900415 |
| 74 | TAOK2 | 0.51778005 |
| 75 | ERN1 | 0.50731713 |
| 76 | STK4 | 0.48520578 |
| 77 | BRD4 | 0.47232980 |
| 78 | MAP2K3 | 0.47055664 |
| 79 | PDK1 | 0.46303430 |
| 80 | MAP3K3 | 0.45469266 |
| 81 | MAP2K6 | 0.45290282 |
| 82 | MAP3K11 | 0.44904779 |
| 83 | FGFR1 | 0.44620065 |
| 84 | FYN | 0.44518333 |
| 85 | HIPK2 | 0.43501446 |
| 86 | IRAK1 | 0.43300511 |
| 87 | CDC7 | 0.41945381 |
| 88 | INSR | 0.41913508 |
| 89 | CDK9 | 0.41685684 |
| 90 | CSF1R | 0.38870263 |
| 91 | DMPK | 0.38532326 |
| 92 | NEK9 | 0.38336538 |
| 93 | BMPR2 | 0.37406183 |
| 94 | CAMK4 | 0.36732858 |
| 95 | YES1 | 0.36138814 |
| 96 | NTRK2 | 0.35655782 |
| 97 | SCYL2 | 0.34828568 |
| 98 | SGK2 | 0.32949823 |
| 99 | FGR | 0.31685594 |
| 100 | MAPK12 | 0.31194882 |
| 101 | NEK6 | 0.30775323 |
| 102 | * IGF1R | 0.30735146 |
| 103 | EGFR | 0.30666377 |
| 104 | PTK6 | 0.30065117 |
| 105 | SGK3 | 0.29872539 |
| 106 | MAPK11 | 0.29688699 |
| 107 | MARK2 | 0.28727917 |
| 108 | RPS6KA5 | 0.26652773 |
| 109 | STK24 | 0.26313887 |
| 110 | IRAK2 | 0.26103855 |
| 111 | MAPK3 | 0.26006355 |
| 112 | RPS6KA6 | 0.25634307 |
| 113 | NEK2 | 0.24303898 |
| 114 | TAOK1 | 0.24115445 |
| 115 | MAPK4 | 0.23596409 |
| 116 | MAP3K8 | 0.23047672 |
| 117 | RAF1 | 0.22399084 |
| 118 | MAPKAPK2 | 0.21428201 |
| 119 | RPS6KC1 | 0.20375163 |
| 120 | TRPM7 | 0.19531143 |
| 121 | ABL1 | 0.19052577 |
| 122 | PRPF4B | 0.17105321 |
| 123 | IRAK3 | 0.17096815 |
| 124 | PASK | 0.16779551 |
| 125 | FGFR2 | 0.16338120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.87535570 |
| 2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.11257546 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.91297642 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.15309787 |
| 5 | * Measles_Homo sapiens_hsa05162 | 2.84939853 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.73815387 |
| 7 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63720866 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63182341 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.26235775 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06924293 |
| 11 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.04783520 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00305592 |
| 13 | * Allograft rejection_Homo sapiens_hsa05330 | 1.82868209 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68656071 |
| 15 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66169281 |
| 16 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.58371917 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.57735748 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.53721882 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43452888 |
| 20 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42776364 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39192597 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38262262 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37400671 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.36932103 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36772603 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36599547 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30396472 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28386119 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28324204 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24851459 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24538006 |
| 32 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20245778 |
| 33 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14330167 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.14225817 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13865486 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.08973593 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07062626 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.06885843 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04112390 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03857215 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.03318921 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.97117961 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96701781 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96090801 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.95447914 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88778937 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87975765 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.86396688 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85379231 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.82575969 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82552001 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81808172 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.77241526 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.76919451 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76381410 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.73756330 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69249272 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65210077 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64387170 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63717185 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62028426 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.61333202 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60276613 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59394630 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59094058 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.58812838 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.58635242 |
| 68 | DNA replication_Homo sapiens_hsa03030 | 0.58495173 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.58433372 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.58035880 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54878917 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54413988 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.53287335 |
| 74 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52543612 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52063533 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52029666 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.51866322 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49372562 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48524110 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.48390319 |
| 81 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47968299 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47676467 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45130682 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42775175 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42477112 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41073044 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41057741 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39400473 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39330772 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38404350 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38262805 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38054861 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38034348 |
| 94 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37754420 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37341700 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.36850212 |
| 97 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36227784 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35584598 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34257522 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32915162 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30479984 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.29581254 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29375187 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29245184 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.27696611 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27022406 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26942894 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.26777975 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26455792 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.24747291 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24418300 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24379341 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.24327359 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23449018 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22581126 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22438486 |
| 117 | Long-term potentiation_Homo sapiens_hsa04720 | 0.22309957 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19690545 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.19120222 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.18878763 |
| 121 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16902638 |

